Recent studies reveal TRE’s potential to enhance mitochondrial function and autophagy in neurodegenerative diseases, while highlighting risks for advanced Huntington’s patients. Emerging r...
New research explores how fasting may improve mitochondrial function and reduce oxidative stress in Huntington’s disease, with implications for other neurodegenerative conditions. Recent clinica...
Exploring a 12-week clinical trial protocol for time-restricted eating in early-stage Huntington’s disease, focusing on mitochondrial function, autophagy, and cognitive improvements. A new 12-we...
Recent studies explore how time-restricted eating may reduce protein aggregation in Huntington’s disease, with implications for Alzheimer’s and Parkinson’s treatment. Emerging resear...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A groundbreaking clinical trial investigates time-restricted eating for Huntington’s disease, exploring neuroprotective mechanisms and practical implementation for patients. The TREAT-HD trial e...
A 12-week clinical trial evaluates the safety and feasibility of time-restricted eating in early-stage Huntington’s disease, focusing on metabolic outcomes and disease biomarkers. A new clinical...
